Nuvectis Pharma Inc (NVCT)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Assets | 20.41M | 16.21M | 24.94M | 22.26M | 19.19M | 19.71M | 18.3M | 17.31M |
Total Current Assets | 20.41M | 16.21M | 24.94M | 22.26M | 19.19M | 19.71M | 18.3M | 17.31M |
Cash and Equivalents | 19.99M | 15.47M | 24.6M | 22.06M | 19.13M | 19.46M | 18.12M | 17.17M |
Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 6.19M | 3.93M | 4.61M | 5.58M | 6.98M | 5.69M | 5.77M | 6.32M |
Total Current Liabilities | 6.19M | 3.93M | 4.61M | 5.58M | 6.98M | 5.69M | 5.77M | 6.32M |
Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -31.99M | -36.03M | -41.74M | -47.62M | -54.25M | -58.42M | -62.84M | -67M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 0 | 6.66M | 20.41M | 19.19M |
Total Current Assets | 0 | 5.83M | 20.41M | 19.19M |
Cash and Equivalents | 0 | 5.74M | 19.99M | 19.13M |
Total Non-Current Assets | -10k | -11.01M | 14.22M | 12.2M |
Total Liabilities | 10k | 2.42M | 6.19M | 6.98M |
Total Current Liabilities | 10k | 2.42M | 6.19M | 6.98M |
Total Non-Current Liabilities | 0 | 0 | 0 | 0 |
Total Equity | -10k | -11.01M | 14.22M | 12.2M |
Common Equity | 0 | 0 | 0 | 0 |
Retained Earnings | -10k | -12.9M | -31.99M | -54.25M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.